Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07455045 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Phase I Study of FZ-AD005 in Patients With High-Grade Glioma (HGG)

StatusNot Yet Recruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
An Open Label, Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of FZ-AD005 in Patients with HGG, especially in DMG and other Recurrent HGG.
Trial Details
NCT Number NCT07455045
Lead Sponsor Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
Conditions
(from sponsor)		 High Grade Glioma (III or IV), Diffuse Midline Glioma (DMG), Glioblastoma (GBM)
Related terms Glioblastoma, Glioma
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov